Dr. Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. Over the last four decades, he has developed laboratory and animal models of myeloma in its microenvironment, which have allowed for both identification of novel targets and validation of novel targeted therapies. He has then rapidly translated these studies to clinical trials culminating in FDA approval of novel targeted therapies, which have markedly improved patient outcomes. He received the American Society of Hematology William Dameshek Prize, the American Association for Cancer Research Joseph H. Burchenal Award, the American Society of Clinical Oncology David A. Karnofsky Award, and the Harvard Medical School Warren Alpert Prize. He is a member of the National Academy of Medicine, and past President of the International Myeloma Society and the American Society of Hematology.
